CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
CVI.00184-06v1
13/11/1237    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gurney, K. B.
Right arrow Articles by Uittenbogaart, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gurney, K. B.
Right arrow Articles by Uittenbogaart, C. H.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, November 2006, p. 1237-1245, Vol. 13, No. 11
1071-412X/06/$08.00+0     doi:10.1128/CVI.00184-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Human Immunodeficiency Virus Persistence and Production in T-Cell Development{triangledown}

Kevin B. Gurney1,{dagger} and Christel H. Uittenbogaart1,2*

Department of Microbiology, Immunology, and Molecular Genetics,1 Department of Pediatrics, UCLA AIDS Institute, Jonsson Comprehensive Cancer Center, David E. Geffen School of Medicine at UCLA, Los Angeles, California2

Received 22 May 2006/ Returned for modification 28 June 2006/ Accepted 12 September 2006

Human immunodeficiency virus type 1 (HIV-1) replication depends on CD4 and coreceptor expression as well as host factors associated with the activation state of the cell. To determine the impact of the activation stage of thymocytes on the HIV-1 life cycle, we investigated R5 and X4 HIV-1 entry, reverse transcription, and expression in discrete thymocyte subsets at different stages of T-cell development. Early after infection, preferential entry and replication of R5 HIV-1 were predominantly detected in mature CD3+/hi CD27+ thymocytes. Thus, R5 HIV-1 targets the stage of development where thymocytes acquire functional responsiveness, which has important implications for HIV pathogenesis. In contrast, X4 HIV-1 expression and replication were primarily found in immature CD3–/+/low CD27 CD69 thymocytes. HIV-1 proviral burden and virus expression in thymocyte subsets correlated with the expression of the highest levels of the respective coreceptor. R5 and X4 HIV-1 entered and completed reverse transcription in all subsets tested, indicating that the activation state of thymocytes and coreceptor expression are sufficient to support full reverse transcription throughout development. Although R5 HIV-1 is expressed mainly in mature CD3+/hi CD27+ thymocytes, 5.3% of HIV-1-infected immature thymocytes express R5 HIV-1, indicating that potentially latent viral DNA can be established early in T-cell development.


* Corresponding author. Mailing address: Department of Microbiology, Immunology, and Molecular Genetics, UCLA School of Medicine, Los Angeles, CA 90095-1747. Phone: (310) 825-1982. Fax: (310) 206-1318. E-mail: uittenbo{at}ucla.edu.

{triangledown} Published ahead of print on 20 September 2006.

{dagger} Present address: Genentech, 1 DNA Way, South San Francisco, CA 94080.


Clinical and Vaccine Immunology, November 2006, p. 1237-1245, Vol. 13, No. 11
1071-412X/06/$08.00+0     doi:10.1128/CVI.00184-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.